Pluri (NASDAQ:PLUR) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.32) by 25 percent. This is a 29.41 percent increase over losses of $(0.34) per share from the same period last year.
Atara Biotherapeutics: Q4 Earnings Insights
Atara Biotherapeutics (NASDAQ:ATRA) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:30 AM. Here’s what…